Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > QNCX Quince Therapeutics > Detailed Quotes

QNCX Quince Therapeutics

Watchlist
0.920
-0.060-6.12%
Trading Session  02/01 14:57 ET
High
0.979
Open
0.979
Turnover
418.08K
Low
0.900
Pre Close
0.980
Volume
447.94K
Market Cap
33.24M
P/E(TTM)
Loss
52wk High
6.800
Shares
36.13M
P/E(Static)
Loss
52wk Low
0.540
Float Cap
25.40M
Bid/Ask %
66.67%
Historical High
121.980
Shs Float
27.60M
Volume Ratio
0.04
Historical Low
0.540
Dividend TTM
--
Div Yield TTM
--
P/B
0.32
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.62%
Amplitude
8.05%
Avg Price
0.933
Lot Size
1
Float Cap
25.40M
Bid/Ask %
66.67%
Historical High
121.980
Shs Float
27.60M
Volume Ratio
0.04
Historical Low
0.540
Dividend TTM
--
P/B
0.32
Dividend LFY
--
Turnover Ratio
1.62%
Amplitude
8.05%
Avg Price
0.933
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Quince Therapeutics, Inc.(formerly Cortexyme, Inc.) is a biopharmaceutical company, which engages in the development and commercialization of therapeutics. Its pipeline composed of COR388, COR588, COR788, COR822, and Coronavirus 3CL protease inhibitor. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.
CEO: Mr. Dirk Thye
Market: NASDAQ
Listing Date: 05/09/2019
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist